MENU
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating autoinflammatory and autoimmune diseases with significant unmet medical need.
Kiniksa has an experienced team with a track record delivering therapies to patients. We are currently advancing a portfolio of product candidates focused on autoinflammatory and autoimmune diseases.
Identify and rapidly develop a pipeline of product candidates with validated mechanisms of action, strong biologic rationale, and specific molecular potential.
We are relentless and focused on putting patients at the center of everything we do and strive to develop life-changing medicines.
clinical stage
molecules
pivotal study in a rare debilitating disease
preclinical stage
molecule
discovery stage
targets
employees committed to helping patients
